ZSCAN2 抗体 (AA 31-80)
Quick Overview for ZSCAN2 抗体 (AA 31-80) (ABIN6736257)
抗原
See all ZSCAN2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 31-80
-
特异性
- Human ZSCAN2
-
预测反应
- Percent identity by BLAST analysis: Human, Mouse, Dog (100%) Bovine (85%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa31-80 of human ZSCAN2 (Q7Z7L9, NP_870992). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Orangutan, Gibbon, Monkey, Marmoset, Mouse, Panda, Dog (100%), Galago, Elephant (92%), Bovine (85%).
Type of Immunogen: Synthetic peptide -
亚型
- IgG
-
-
anti-Zinc Finger and SCAN Domain Containing 2 (ZSCAN2) (AA 1-433) antibody
ZSCAN2 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Zinc Finger and SCAN Domain Containing 2 (ZSCAN2) (Internal Region) antibodyZSCAN2 适用: 人, 小鼠 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Zinc Finger and SCAN Domain Containing 2 (ZSCAN2) (C-Term) antibodyZSCAN2 适用: 人, 犬, 大鼠, Cow, Pig, 豚鼠, 马, 兔, 猴, Bat WB 宿主: 兔 Polyclonal unconjugated
anti-Zinc Finger and SCAN Domain Containing 2 (ZSCAN2) (N-Term) antibodyZSCAN2 适用: 人, 犬 WB 宿主: 兔 Polyclonal unconjugated
anti-Zinc Finger and SCAN Domain Containing 2 (ZSCAN2) (AA 50-150) antibodyZSCAN2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Zinc Finger and SCAN Domain Containing 2 (ZSCAN2) (AA 117-146), (N-Term) antibodyZSCAN2 适用: 人 WB, FACS 宿主: 兔 Polyclonal RB33075 unconjugated
anti-Zinc Finger and SCAN Domain Containing 2 (ZSCAN2) (Middle Region) antibodyZSCAN2 适用: 人, 犬, 小鼠, 大鼠, Cow, 豚鼠, 马, 兔 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Approved: WB (0.2 - 1 μg/mL)
-
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- After adding water, will consist of PBS buffer with 2 % sucrose
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
